PDS Biotechnology (NASDAQ:PDSB) Receives “Buy” Rating from HC Wainwright
HC Wainwright restated their buy rating on shares of PDS Biotechnology (NASDAQ:PDSB – Free Report) in a research note published on Friday,Benzinga reports. They currently have a $21.00 target price on the stock. Several other brokerages also recently issued reports on PDSB. B. Riley reduced their price target on shares of PDS Biotechnology from $9.00 […]
